COMBO-DN Survey

Home
Who we are
What we do
DAYDEIC
Type 1 and beyond
Contact Us
Donate

Home /
COMBO-DN Survey /

We value your opinion. Kindly go through few important questions and share your views on it.

Name

Email ID

Mobile No

City

State

Pin Code

PAN

The above information is correct to best of knowledge & I do hereby give my consent to use the information of this survey for research work in future.

1. In Your Clinical Practice, rate the prevalence of patients ranking Highest to Lowest among the followings - a) Neuropathy, b) Epilepsy, c) Stroke, d) Migraine e) Others.

2. In Epilepsy Management, your Choice of 1st line treatment in the preference of Highest to Lowest among the followings: a) Pheniytoin, b) Sodium Valproate, c) Levetiracetam, d) Any other.

3. In what % of Patients , you need more than 1 Anti-Epileptic medicine?

a) <10%

b) 10-20%

c) 20-30%

d) 30-40%

c) >50%

4. In uncontrolled patients of Epilepsy, what are your treatment choices?

a) Up Titrate Dose to Max

b) Add On other Antiepileptic

5. What is your favorite Levetiracetam Brand & Strengths?

6. In Neuropathy pain, 1st line treatments is _____

a) Pregabaline

b) Gabapentine

c) Pregabaline & Combinations

7. What % of patients need a combination treatment in Neuropathic pain?

a) 5-10%

b) 10-20%

c) 20-30%

d) >50%

8. What is the right patient profile for Pregabaline+Duloxitine combination ?

a) Neuropathic Pain

b) Neuropathic Pain with Anxiety

c) Any Other

9. How many such patients comes across to you in your clinical practice?

a) 5-10%

b) 10-20%

c) 20-30%

d) >50%

10. What duration you will continue this combination to your patients?

a) 1 -3 Months

b) 3-6 Months

c) 6-12 Months

d) More than 1 Year/ Lifelong

Time's up